Author:
Sessa Francesco,Polverino Paolo,Bisegna Claudio,Siena Giampaolo,Lo Re Mattia,Spatafora Pietro,Pecoraro Alessio,Rivetti Anna,Conte Francesco Lupo,Cocci Andrea,Villari Donata,Minervini Andrea,Gacci Mauro,Li Marzi Vincenzo,Serni Sergio,Campi Riccardo
Abstract
ObjectiveTo date, several ultra-minimally-invasive surgical techniques are available for the treatment of male LUTS due to benign prostatic obstruction (BPO). Herein we report our preliminary experience with SoracteLite™ TPLA for the treatment of carefully selected patients with LUTS due to BPO.MethodsData from all consecutive patients undergoing TPLA at our institution between April 2021 and February 2022 were prospectively collected in a specific database. Data regarding functional and sexual outcomes evaluated by validated questionnaires and uroflowmetry were analyzed. All the procedure were performed in an outpatient setting, under local anesthesia and conscious sedation, using EchoLaser device, a multisource diode laser generator.ResultsOverall, 38 patients underwent TPLA at our institution during the study period. The median prostate volume was 46 ml (IQR 38-71). The median time to complete the procedure was 31 min (IQR 28-37). All patients but one were discharged within 8 hours of hospital stay. No perioperative Clavien-Dindo grade ≥2 complications were recorded. Median improvement in Qmax was 17%, 24% and 32% at 1 month, 3 months and last follow-up after surgery; as a result, the median postoperative IPSS at 1 month, 3 months and at last follow-up decreased by -14%, -36% and -35%, respectively. All patients preserved ejaculatory and sexual function. Two patients (5%), catheter carriers before the procedure, experienced acute urinary retention after TPLA treatment and required replacement of an indwelling catheter.ConclusionsTPLA can be a feasible, safe and effective ultra-minimally-invasive procedure for carefully selected patients with LUTS due to BPO.
Reference27 articles.
1. GravasS
CornuJN
GacciM
EAU guidelines on management of non-neurogenic Male lower urinary tract symptoms (LUTS), incl. benign prostatic obstruction (BPO). version 2021. edn. presented at the EAU annual congress Milan2021
2. New ultra-minimally invasive surgical treatment for benign prostatic hyperplasia: A systematic review and analysis of comparative outcomes;Checcucci;Eur Urol Open Sci,2021
3. Reply to davide rosati, riccardo lombardo, cosimo de nunzio, constantino Leonardo, and Andrea tubaro's words of wisdom re: Transperineal interstitial laser ablation of the prostate, a novel option for minimally invasive treatment of benign prostatic obstruction. eur urol 2021;80:673-4;De Rienzo;Eur Urol,2022
4. Minimally invasive treatments for lower urinary tract symptoms in men with benign prostatic hyperplasia: a network meta-analysis;Franco;Cochrane Database Syst Rev,2021
5. Emerging minimally invasive transurethral treatments for benign prostatic hyperplasia: a systematic review with meta-analysis of functional outcomes and description of complications;Manfredi;Minerva Urol Nephrol,2022
Cited by
7 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献